Japan Intellectual Property Rights: ACTIVIN TYPE 2 RECEPTOR-BINDING PROTEIN, AND USE OF THE SAME

Japan, Oct. 30 -- ADIMAB LLC,ACCELERON PHARMA INC has got intellectual property rights for 'ACTIVIN TYPE 2 RECEPTOR-BINDING PROTEIN, AND USE OF THE SAME.' Other related details are as follows:

Application Number: JP,2023-198762

Category (FI): C07K16/28,A61P3/04,A61P3/00,A61P29/00,A61K38/16,A61K39/395@C,A61P27/02,A61P25/28,A61P25/00,A61P3/10,A61P35/00,A61P37/06,A61P43/00,121,A61P9/00,A61P9/04,C12P21/08,A61P19/10,A61P21/00,A61P9/12,C12N5/10,C12N5/071,A61K39/395@D,A61K39/395@L,A61P19/00,A61K45/00,A61K39/395@N,A61P1/16,A61P11/00,A61P17/02,C12N15/63@Z,C12N15/13,C07K16/46

Stage: Grant (IP right document published.)

Filing Date: Nov. 24, 2023

Publication Date: Feb. 28, 2024

The original document can be viewed at: https://www.j-platpat.inpit....